Articles by Michael Goodman - Pharmaceutical Executive


Articles by Michael Goodman

A Very Specialty Moment

Big Pharma is on a shopping spree for biologics and other specialty products. It has the money to buy them. But does it have the mojo to develop and market them successfully—or will the midsize biopharmas make their big move?
Jun 1, 2007

While the most sought-after opinion leaders are often older, well-established physicians, companies should also be aware of the rising stars. Younger, up-and-coming specialists who are beginning to publish are often more cutting-edge and open to experimental approaches.


Click here